Orexo AB

DIRAPARID

Pharmaceutical preparations, namely for the treatment of heartburn, migraine, insomnia, urinary incontinence, asthma, rhinitis, osteoarthrosis, inflammatory diseases, chronic obstructive pulmonary disease (COPD) as well as pain relief and pain killers;

DUPRAFAM

Pharmaceutical preparations, namely for the treatment of heartburn, migraine, insomnia, urinary incontinence, asthma, rhinitis, osteoarthrosis, inflammatory diseases, chronic obstructive pulmonary disease (COPD) as well as pain relief and pain killers;

ENVIDIZ

Pharmaceutical preparations for human use for the treatment of neurological diseases, opioid dependence and inflammatory diseases; pain relief preparations and pain killers for human use;The wording ENVIDIZ has no meaning in a foreign language.;

EVATE

Medical preparation used as a narcotic antagonist; Drug delivery devices, namely, nasal delivery devices filled with pharmaceutical preparations for use in the treatment of narcotic overdose; Pharmaceutical preparations in the form of powders for treatment of opioid addiction and overdose;

GUIDE360

GUIDE THREE HUNDRED SIXTY; GUIDE THREE SIX ZERO;Therapeutic and behavioural health services, namely, medical counseling, psychological counseling, medical advice and medical information provided to patients with, and care givers treating, excessive alcohol consumption, anxiety, depression, chronic pain or mental health issues; therapeutic and behavioural health services, namely, medical counseling, psychological counseling, medical advice and medical information provided to patients suffering from, and care givers treating, excessive alcohol consumption, anxiety, depression, chronic pain or mental health issues via an online digital platform; conducting medical and therapeutic examinations for insurance purposes on patients suffering from excessive alcohol consumption, anxiety, depression, chronic pain or mental health issues;

IZOLVE

Education; providing of training;Pharmaceutical preparations for human use;I SOLVE;Medical services, namely support, advice and information to patients;

MODIA

Providing of training and further education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; further education in the nature of courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from opioid addiction and for medical personnel specialized on the treatment of opioid addiction;

MODIA

Providing of training and further education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; further education in the nature of courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from opioid addiction and for medical personnel specialized on the treatment of opioid addiction;The mark consists of the stylized wording MODIA in red-orange. The color white represents transparent background and is not claimed as a feature of the mark.;Downloadable therapeutic medical and counseling content, namely, downloadable written and graphic materials, downloadable forms, downloadable electronic data files, downloadable multimedia files featuring information, instructions, charts, studies, data in the field of opioid dependence and addiction, treatment of opioid dependence and addiction, related health and wellness, and coaching and consulting information therefor; downloadable electronic publications, namely, downloadable newsletters and articles for use by medical professionals and patients in the field of field of opioid dependence, addiction and treatment;The color(s) red-orange is/are claimed as a feature of the mark.;Therapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, opioid dependence and opioid addiction; computer-based interactive medical support services, namely, providing online medical advice and medical assistance services relating to the treatment of opioid dependent and addicted patients and their families;Providing a website featuring digital therapeutic technology for the treatment of opioid dependence and opioid addiction; providing an online non-downloadable digital therapeutic software platform for providing behavioral health services in the nature of coaching, counseling, advice in the field of opioid dependence, addiction and treatment; conducting medical and scientific and technological research in the field of opioid dependence and opioid addiction; conducting technological research and design of digital therapeutics, namely, technological research and design of computer software for interactive and online psychological intervention and counseling in the field of opioid dependence and addiction; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of opioid dependence and addiction and the treatment of opioid dependence and addiction;

MODIA

Downloadable, printable therapeutic medical and counseling content, namely, information, forms, instructions, charts, studies, data and related coaching and advice in the field of opioid dependence and addiction, treatment of opioid dependence and addiction, and related health and wellness; electronic publications, namely, newsletters and articles for use by medical professionals and patients in the field of opioid dependence, addiction and treatment;

MODIA

Therapeutic services, namely, medical counseling, psychological counseling, medical advice and medical information provided to patients with, and care givers treating, opioid dependence and opioid addiction; therapeutic services, namely, medical counseling, psychological counseling, medical advice and medical information provided to patients with, and care givers treating, opioid dependence and opioid addiction via an online digital platform;

OREXO

Pharmaceutical preparations, namely, for the treatment of heartburn, migraine, insomnia, urinary incontinence, asthma, rhinitis, oesteoarthrosis, inflammatory diseases, chronic obstructive pulmonary disease (COPD) opioid dependence, cancer as well as pain relief and pain killers, to the exclusion of anti-infectious products and antibiotics;Licensing of intellectual property within the field of medicines;Pharmaceutical advice;Conducting basic and clinical research in the field of medicine, pharmacology and testing of pharmaceuticals and consultation related thereto;

PALBUNOX

Pharmaceutical preparations for human use for the treatment of neurological diseases, opioid dependence and inflammatory diseases; pain relief preparations and pain killers for human use;The wording PALBUNOX has no meaning in a foreign language.;

RHINOXAL

Medical preparation for use as a narcotic antagonist in the treatment of narcotic overdose; Drug delivery devices, namely, nasal delivery devices sold filled with pharmaceutical preparations for use in the treatment of narcotic overdose; Pharmaceutical preparations in the form of powders for treatment of opioid addiction and overdose;

RISE

[ Educational services, namely, providing instructional courses and seminars in the field of opioid dependence and opioid addiction to enable further self-directed education and recovery; ] providing training in the field of opioid dependence and opioid addiction to enable further self-directed education and recovery;The mark consists of the word RISE in dark orange font, beneath a design formed by three curved bands in the colors dark yellow, dark orange and dark purple, with light yellow, light orange and light purple rays superimposed on the curved bands. The colors black, white and/or gray represent background, outlining, shading and/or transparent areas and are not part of the mark.;The color(s) light yellow, dark yellow, light orange, dark orange, light purple and dark purple is/are claimed as a feature of the mark.;Medical services in the nature of medical support services, namely, medical counseling, psychological counseling, medical advice and medical information provided to patients with, and care givers treating, opioid dependence and opioid addiction;

SUBLINOX

Pharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, such as pain, insomnia and migraine.;

TWIMBLET

Pharmaceutical preparations, namely for the treatment of heartburn, migraine, insomnia, urinary incontinence, ashthma, rhinitis, osteoarthrosis, inflammatory diseases, chronic obstructive pulmonary disease (COPD) as well as pain relief and pain killers;

VOXIV

Medical preparation used as a narcotic antagonist; Drug delivery devices, namely, nasal delivery devices filled with pharmaceutical preparations for use in the treatment of narcotic overdose; Pharmaceutical preparations in the form of powders for treatment of opioid addiction and overdose;

ZOLIREST

Pharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, namely, pain, insomnia and migraine;ZOLI REST;

ZUBIQUE

Pharmaceutical preparations for human use for the treatment of neurological diseases, opioid dependence and inflammatory diseases; pain relief preparations and pain killers for human use;The wording ZUBIQUE has no meaning in a foreign language.;

ZUBLINOX

Pharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, such as pain, insomnia and migraine;

ZUBSOLV

Pharmaceutical preparations for human use for the treatment of opioid dependence; pain relief preparations and pain killers for human use;The wording ZUBSOLV has no meaning in a foreign language.;

ZUBSOLV

The mark consists of the word ZUBSOLV in stylized purple font, beneath a triangular shape formed by three orange curved lines. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.;Pharmaceutical preparations for human use for the treatment of opioid dependence; pain relief preparations and pain killers for human use;The color(s) orange (pms 1655-pms130) and purple (pms 2627) is/are claimed as a feature of the mark.;